Endometriosis
📧 Sign up to get email alerts when something new happens for Endometriosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-10-10FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from URONOVA Pharmaceuticals.
-
FDA approval · 2014-10-07FDA Approved: ZOLADEX — Supplemental Application (TerSera Therapeutics LLC)
The FDA approved a supplemental application for ZOLADEX (goserelin) filed by TerSera Therapeutics LLC. This action typically updates labelin…
-
CLINICAL_TRIALS research · 2014-09-12Clinical Trial Update: Impact of Deep Endometriosis Surgery on Bladder Function
This update describes a clinical trial investigating the effect of surgery for deep infiltrating endometriosis on bladder function. The spon…
-
CLINICAL_TRIALS research · 2014-09-11Clinical Trial Update: Continuous Versus Cyclic Oral Contraceptives for Endometriosis [Phase 4]
A Phase 4 trial comparing continuous versus cyclic oral contraceptives for endometriosis, focusing on symptoms like dysmenorrhea and pelvic …
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis [Phase 2]
A Phase 2 safety and efficacy trial of Proellex for symptomatic endometriosis in premenopausal women was terminated, with results posted in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-07-18FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approves a supplemental application for VABRINTY (leuprolide acetate) submitted by Uronova Pharmaceuticals, Inc. The approval updates th…
-
CLINICAL_TRIALS trial_result · 2014-07-01Clinical Trial Update: CA 125 and VAS Pain Score Changes to Diagnose Endometriosis
This completed clinical trial evaluated whether CA125 biomarker levels and Visual Analog Scale pain scores can aid in diagnosing endometrios…
-
CLINICAL_TRIALS trial_result · 2014-06-18Clinical Trial Update: The Efficacy and Safety Study of a New Cross-linked Hyaluronan Hydrogel in the Reduction of Postsurgical Peritoneal Adhesions [Phase 1, Phase 2]
Update on a Phase 1/2 trial evaluating a cross-linked hyaluronan hydrogel to reduce postsurgical peritoneal adhesions, with safety and preli…
-
CLINICAL_TRIALS trial_result · 2014-06-13Clinical Trial Update: Efficacy and Safety, Long-Term Study of NPC-01 to Treat Dysmenorrhea Associated With Endometriosis [Phase 3]
Phase 3 long-term study of NPC-01 for dysmenorrhea associated with endometriosis has completed. Efficacy and safety results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: PGL2001 Proof of Concept Study in Symptomatic Endometriosis [Phase 2]
Phase 2 proof-of-concept study of PGL2001 for symptomatic endometriosis has completed. The trial status is listed as COMPLETED on ClinicalTr…
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: PGL5001 Proof of Concept Study in Inflammatory Endometriosis [Phase 2]
A Phase 2 proof-of-concept study of PGL5001 in inflammatory endometriosis has completed. This status indicates that final trial results are …
-
FDA label_change · 2014-05-30FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from URONOVA Pharmaceuticals. This notice relates to regulatory ac…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: A Randomized, Placebo-controlled, Double-blind Study of KLH-2109 in Patients With Endometriosis (2) [Phase 2]
A Phase 2 randomized, placebo-controlled, double-blind trial evaluating KLH-2109 for endometriosis has been completed.
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: A Phase II Randomized Open Label Study of KLH-2109 in Patients With Endometriosis [Phase 2]
A Phase II randomized open-label study evaluating KLH-2109 for endometriosis has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain [Phase 2]
A Phase 2 clinical trial evaluating DR-2001 for endometriosis-related pelvic pain has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis [Phase 2]
A Phase 2 long-term extension study of TAK-385 for endometriosis has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-04Clinical Trial Update: Edessy Stem Cell Score (ESS), Endometrium, Endometrioma [NA]
Completed clinical trial update on the Edessy Stem Cell Score (ESS) related to endometrium in endometriosis and ovarian endometrioma, sponso…
-
FDA approval · 2014-03-14FDA Approved: TRELSTAR — Supplemental Application (Verity Pharmaceuticals Inc.)
The FDA approved a supplemental application for TRELSTAR (triptorelin pamoate) submitted by Verity Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2014-02-25Clinical Trial Update: Efficacy and Safety of TAK-385 in the Treatment of Endometriosis [Phase 2]
A Phase 2 trial evaluating TAK-385 for endometriosis has completed, with results assessing its efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Non-Interventional Study of Zoladex in Endometriosis
A non-interventional study evaluating Zoladex (goserelin) for endometriosis has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Study Comparing Conventional vs. Robotic-assisted Laparoscopic Hysterectomy [NA]
This clinical trial compared conventional laparoscopic hysterectomy with robotic-assisted laparoscopic hysterectomy and has completed.
-
CLINICAL_TRIALS trial_result · 2014-02-10Clinical Trial Update: Use of Antioxidant in Endometriotic Women to Improve Intracytoplasmic Sperm Injection (ICSI) [Phase 2]
A Phase 2 trial evaluating an antioxidant strategy to improve ICSI outcomes in women with endometriosis has completed.
-
CLINICAL_TRIALS withdrawal · 2014-02-07Clinical Trial Update: Open-Label Extension Study to ZPE-202 [Phase 2]
A Phase 2 open-label extension study (ZPE-202) for endometriosis has been withdrawn; no further development for this study is indicated by t…
-
CLINICAL_TRIALS trial_result · 2014-01-24Clinical Trial Update: Medical Treatment of Endometriosis-Associated Pelvic Pain [Phase 3]
Phase 3 clinical trial update on medical treatment for endometriosis-associated pelvic pain; trial has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Safety and Efficacy of SH T00660AA in Treatment of Endometriosis [Phase 3]
A completed Phase 3 trial evaluating the safety and efficacy of SH T00660AA for endometriosis, sponsored by Bayer.